Efficacy and Safety of Blonanserin Oral Tablet in Adolescents with Schizophrenia: A 6-Week, Randomized Placebo-Controlled Study

Objectives: To evaluate the short-term efficacy and safety of blonanserin in adolescents with schizophrenia. Methods: This 6-week multicenter, double-blind, randomized, placebo-controlled study investigated fixed-dose blonanserin (8 or 16 mg/day) in patients 12–18 years of age diagnosed with schizop...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Takuya, Sugimoto, Saori, Sakaguchi, Reiko, Nakamura, Hiroshi, Ishigooka, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884167/
https://www.ncbi.nlm.nih.gov/pubmed/35133884
http://dx.doi.org/10.1089/cap.2021.0013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8884167/
https://www.ncbi.nlm.nih.gov/pubmed/35133884
http://dx.doi.org/10.1089/cap.2021.0013

Ejemplares similares